Cargando…
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart
BACKGROUND: Human mutations in the X‐linked lysosome‐associated membrane protein‐2 (LAMP2) gene can cause a multisystem Danon disease or a primary cardiomyopathy characterized by massive hypertrophy, conduction system abnormalities, and malignant ventricular arrhythmias. We introduced an in‐frame LA...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649277/ https://www.ncbi.nlm.nih.gov/pubmed/34459252 http://dx.doi.org/10.1161/JAHA.120.018829 |
_version_ | 1784610960784228352 |
---|---|
author | Alcalai, Ronny Arad, Michael Wakimoto, Hiroko Yadin, Dor Gorham, Joshua Wang, Libin Burns, Elia Maron, Barry J. Roberts, William C. Konno, Tetsuo Conner, David A. Perez‐Atayde, Antonio R. Seidman, Jon G. Seidman, Christine E. |
author_facet | Alcalai, Ronny Arad, Michael Wakimoto, Hiroko Yadin, Dor Gorham, Joshua Wang, Libin Burns, Elia Maron, Barry J. Roberts, William C. Konno, Tetsuo Conner, David A. Perez‐Atayde, Antonio R. Seidman, Jon G. Seidman, Christine E. |
author_sort | Alcalai, Ronny |
collection | PubMed |
description | BACKGROUND: Human mutations in the X‐linked lysosome‐associated membrane protein‐2 (LAMP2) gene can cause a multisystem Danon disease or a primary cardiomyopathy characterized by massive hypertrophy, conduction system abnormalities, and malignant ventricular arrhythmias. We introduced an in‐frame LAMP2 gene exon 6 deletion mutation (denoted L2(Δ6)) causing human cardiomyopathy, into mouse LAMP2 gene, to elucidate its consequences on cardiomyocyte biology. This mutation results in in‐frame deletion of 41 amino acids, compatible with presence of some defective LAMP2 protein. METHODS AND RESULTS: Left ventricular tissues from L2(Δ6) and wild‐type mice had equivalent amounts of LAMP2 RNA, but a significantly lower level of LAMP2 protein. By 20 weeks of age male mutant mice developed left ventricular hypertrophy which was followed by left ventricular dilatation and reduced systolic function. Cardiac electrophysiology and isolated cardiomyocyte studies demonstrated ventricular arrhythmia, conduction disturbances, abnormal calcium transients and increased sensitivity to catecholamines. Myocardial fibrosis was strikingly increased in 40‐week‐old L2(Δ6) mice, recapitulating findings of human LAMP2 cardiomyopathy. Immunofluorescence and transmission electron microscopy identified mislocalization of lysosomes and accumulation of autophagosomes between sarcomeres, causing profound morphological changes disrupting the cellular ultrastructure. Transcription profile and protein expression analyses of L2(Δ6) hearts showed significantly increased expression of genes encoding activators and protein components of autophagy, hypertrophy, and apoptosis. CONCLUSIONS: We suggest that impaired autophagy results in cardiac hypertrophy and profound transcriptional reactions that impacted metabolism, calcium homeostasis, and cell survival. These responses define the molecular pathways that underlie the pathology and aberrant electrophysiology in cardiomyopathy of Danon disease. |
format | Online Article Text |
id | pubmed-8649277 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86492772022-01-14 LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart Alcalai, Ronny Arad, Michael Wakimoto, Hiroko Yadin, Dor Gorham, Joshua Wang, Libin Burns, Elia Maron, Barry J. Roberts, William C. Konno, Tetsuo Conner, David A. Perez‐Atayde, Antonio R. Seidman, Jon G. Seidman, Christine E. J Am Heart Assoc Original Research BACKGROUND: Human mutations in the X‐linked lysosome‐associated membrane protein‐2 (LAMP2) gene can cause a multisystem Danon disease or a primary cardiomyopathy characterized by massive hypertrophy, conduction system abnormalities, and malignant ventricular arrhythmias. We introduced an in‐frame LAMP2 gene exon 6 deletion mutation (denoted L2(Δ6)) causing human cardiomyopathy, into mouse LAMP2 gene, to elucidate its consequences on cardiomyocyte biology. This mutation results in in‐frame deletion of 41 amino acids, compatible with presence of some defective LAMP2 protein. METHODS AND RESULTS: Left ventricular tissues from L2(Δ6) and wild‐type mice had equivalent amounts of LAMP2 RNA, but a significantly lower level of LAMP2 protein. By 20 weeks of age male mutant mice developed left ventricular hypertrophy which was followed by left ventricular dilatation and reduced systolic function. Cardiac electrophysiology and isolated cardiomyocyte studies demonstrated ventricular arrhythmia, conduction disturbances, abnormal calcium transients and increased sensitivity to catecholamines. Myocardial fibrosis was strikingly increased in 40‐week‐old L2(Δ6) mice, recapitulating findings of human LAMP2 cardiomyopathy. Immunofluorescence and transmission electron microscopy identified mislocalization of lysosomes and accumulation of autophagosomes between sarcomeres, causing profound morphological changes disrupting the cellular ultrastructure. Transcription profile and protein expression analyses of L2(Δ6) hearts showed significantly increased expression of genes encoding activators and protein components of autophagy, hypertrophy, and apoptosis. CONCLUSIONS: We suggest that impaired autophagy results in cardiac hypertrophy and profound transcriptional reactions that impacted metabolism, calcium homeostasis, and cell survival. These responses define the molecular pathways that underlie the pathology and aberrant electrophysiology in cardiomyopathy of Danon disease. John Wiley and Sons Inc. 2021-08-28 /pmc/articles/PMC8649277/ /pubmed/34459252 http://dx.doi.org/10.1161/JAHA.120.018829 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Alcalai, Ronny Arad, Michael Wakimoto, Hiroko Yadin, Dor Gorham, Joshua Wang, Libin Burns, Elia Maron, Barry J. Roberts, William C. Konno, Tetsuo Conner, David A. Perez‐Atayde, Antonio R. Seidman, Jon G. Seidman, Christine E. LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart |
title |
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart |
title_full |
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart |
title_fullStr |
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart |
title_full_unstemmed |
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart |
title_short |
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart |
title_sort | lamp2 cardiomyopathy: consequences of impaired autophagy in the heart |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649277/ https://www.ncbi.nlm.nih.gov/pubmed/34459252 http://dx.doi.org/10.1161/JAHA.120.018829 |
work_keys_str_mv | AT alcalaironny lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT aradmichael lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT wakimotohiroko lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT yadindor lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT gorhamjoshua lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT wanglibin lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT burnselia lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT maronbarryj lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT robertswilliamc lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT konnotetsuo lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT connerdavida lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT perezataydeantonior lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT seidmanjong lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart AT seidmanchristinee lamp2cardiomyopathyconsequencesofimpairedautophagyintheheart |